From a molecular perspective, Lucentis was designed to stay in the eye and have a short half-life (two hours), while Avastin was designed to enter the circulatory system and to stick around to fight off cancer (a half-life of 20 days).
Withdrawal-type symptoms typically resolve in a week or two depending on the half-life of the specific benzodiazepine involved, which suggests that at a gross level, the brain returns to normal fairly quickly.